medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2021, Número 3

<< Anterior Siguiente >>

Rev Biomed 2021; 32 (3)


El tratamiento con resiniferatoxina exhibe propiedades antiinflamatorias en un modelo murino de inflamación inducida por lipopolisacárido

Muñoz-Carrillo JL, Villalobos-Gutiérrez PT, Puebla-Pérez AM, López-Luna A, Flores-de la Torre JA, Alvarez-Barreto I, Gutiérrez-Coronado O

Idioma: Español
Referencias bibliográficas: 40
Paginas: 137-146
Archivo PDF: 1177.46 Kb.


RESUMEN

Introducción. La inflamación es una respuesta fisiológica protectora del sistema inmunológico frente a diversos estímulos, tales como la infección o daño celular, la cual, al no resolverse de manera adecuada, puede ser perjudicial para le hospedero. En la búsqueda de nuevas alternativas terapéuticas que inhiban la respuesta inflamatoria, diversos estudios han reportado el uso de varias moléculas, tales como la resiniferatoxina (RTX), un potente agonista del receptor de potencial transitorio vanilloide (TRPV)-1.
Objetivo. Evaluar si el tratamiento con RTX exhibe propiedades antiinflamatorias, utilizando un modelo murino de inflamación inducida por lipopolisacárido (LPS).
Material y métodos. Se estimularon ratones BALB/c con LPS y posteriormente fueron tratados con dexametasona (DEX), capsaicina (CAP), Bay 11-7082, capsazepina (CPZ) y RTX. Además, otros grupos de ratones fueron estimulados con LPS y luego tratados con Bay 11-7082 y CPZ más RTX. Después del tratamiento, se determinaron cuantitativamente los niveles plasmáticos de prostaglandina (PG)-E2, óxido nítrico (NO), interleucina (IL)-1β y factor de necrosis tumoral (TNF)- α utilizando kits de Enzyme- Linked ImmunoSorbent Assay ELISA.
Resultados. El tratamiento con RTX disminuyó de manera significativa los niveles plasmáticos de PGE2, NO, IL-1β y TNF- α. Así mismo, se observó que los tratamientos con Bay 11-7082 y CPZ más RTX mostraron un efecto antiinflamatorio sinérgico, observándose una disminución significativa más pronunciada en los niveles plasmáticos de TNF- α y PGE2.
Conclusión. Estos hallazgos sugieren que el tratamiento con RTX muestra propiedades antiinflamatorias, aparentemente asociadas con la vía de señalización factor nuclear (NF)-κB, independiente de los receptores TRPV1, colocando a la RTX como un fármaco potencial en el tratamiento de enfermedades inflamatorias


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Kotas ME, Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell. 2015 Feb; 160(5): 816- 27. doi: 10.1016/j.cell.2015.02.010.

  2. Muñoz-Carrillo JL, Castro-García FP, Gutiérrez- Coronado O, Moreno-García MA, Contreras-Cordero JF. Physiology and pathology of innate immune response against pathogens. In: Rezaei N. Physiology and pathology of immunology. England: IntechOpen; 2017. P. 99-134. doi: 10.5772/intechopen.70556

  3. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010 Mar;140(6): 771-6. doi: 10.1016/j. cell.2010.03.006.

  4. Stewart I, Schluter PJ, Shaw GR. Cyanobacterial lipopolysaccharides and human health - a review. Environ Health. 2006 Mar; 5: 7. doi: 10.1186/1476- 069X-5-7.

  5. Gu L, Meng R, Tang Y, Zhao K, Liang F, Zhang R et al. Toll-like receptor 4 signaling licenses the cytosolic transport of lipopolysaccharide from bacterial outer membrane vesicles. Shock. 2019 Feb; 51(2): 256-65. doi: 10.1097/SHK.0000000000001129.

  6. Vergnolle N. The inflammatory response. Drug Dev Res. 2003 Sep; 59(4): 375-81. doi: 10.1002/ddr.10306.

  7. Headland SE, Norling LV. The resolution of inflammation: Principles and challenges. Semin Immunol. 2015 May; 27(3): 149-60. doi: 10.1016/j.smim.2015.03.014.

  8. Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010 Mar; 140(6): 935-50. doi: 10.1016/j. cell.2010.02.043.

  9. Muñoz-Carrillo JL, Muñoz-López JL, Muñoz- Escobedo JJ, Maldonado-Tapia C, Gutiérrez-Coronado O, Contreras-Cordero JF et al. Therapeutic effects of resiniferatoxin related with immunological responses for intestinal inflammation in Trichinellosis. Korean J Parasitol. 2017 Dec; 55(6): 587-99. doi: 10.3347/ kjp.2017.55.6.587.

  10. Carnevale V, Rohacs T. TRPV1: A target for rational drug design. Pharmaceuticals (Basel). 2016 Aug; 9(3): 52. doi: 10.3390/ph9030052.

  11. Singh S, Natarajan K, Aggarwal BB. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-kappa B activation by diverse agents. J Immunol. 1996 Nov; 157(10): 4412-20. PMID: 8906816. Available from: https://www.jimmunol. org/content/157/10/4412.long

  12. Chen CW, Lee ST, Wu WT, Fu WM, Ho FM, Lin WW. Signal transduction for inhibition of inducible nitric oxide synthase and cyclooxygenase-2 induction by capsaicin and related analogs in macrophages. Br J Pharmacol. 2003 Nov; 140(6): 1077-87. doi: 10.1038/ sj.bjp.0705533.

  13. Ueda K, Tsuji F, Hirata T, Takaoka M, Matsumura Y. Preventive effect of TRPV1 agonists capsaicin and resiniferatoxin on ischemia/reperfusion-induced renal injury in rats. J Cardiovasc Pharmacol. 2008 May; 51(5): 513-20. doi: 10.1097/FJC.0b013e31816f6884.

  14. Muñoz-Carrillo JL, Muñoz-Escobedo JJ, Maldonado- Tapia CH, Chávez-Ruvalcaba F, Moreno-García MA. Resiniferatoxin lowers TNF-α, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection. Parasite Immunol. 2017 Jan; 39(1). doi: 10.1111/pim.12393.

  15. Muñoz-Carrillo JL, Contreras-Cordero JF, Muñoz- López JL, Maldonado-Tapia CH, Muñoz-Escobedo JJ, Moreno-García MA. Resiniferatoxin modulates the Th1 immune response and protects the host during intestinal nematode infection. Parasite Immunol. 2017 Sep; 39(9). doi: 10.1111/pim.12448.

  16. Rivest S, Laflamme N, Nappi RE. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J Neurosci. 1995 Apr; 15(4): 2680-95. doi: 10.1523/JNEUROSCI.15-04-02680.1995.

  17. Demirbilek S, Ersoy MO, Demirbilek S, Karaman A, Gürbüz N, Bayraktar N et al. Small-dose capsaicin reduces systemic inflammatory responses in septic rats. Anesth Analg. 2004 Nov; 99(5): 1501-7. doi: 10.1213/01. ANE.0000132975.02854.65.

  18. Nguyen TL, Nam YS, Lee SY, Kim HC, Jang CG. Effects of capsazepine, a transient receptor potential vanilloid type 1 antagonist, on morphine-induced antinociception, tolerance, and dependence in mice. Br J Anaesth. 2010 Nov; 105(5): 668-74. doi: 10.1093/bja/aeq212.

  19. Irrera N, Vaccaro M, Bitto A, Pallio G, Pizzino G, Lentini M et al. BAY 11-7082 inhibits the NF-κB and NLRP3 inflammasome pathways and protects against IMQinduced psoriasis. Clin Sci (Lond). 2017 Mar; 131(6): 487-98. doi: 10.1042/CS20160645.

  20. Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem. 2002 Nov; 71: 635-700. doi: 10.1146/annurev.biochem.71.110601.135414.

  21. Aggarwal BB, Gupta SC, Kim JH. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood. 2012 Jan; 119(3): 651-65. doi: 10.1182/blood-2011-04-325225.

  22. Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010 Mar; 20(2): 87-103. doi: 10.1615/ critreveukargeneexpr.v20.i2.10.

  23. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009 Apr; 27: 519-50. doi: 10.1146/annurev. immunol.021908.132612.

  24. Akiba Y, Kaunitz JD. Prostaglandin pathways in duodenal chemosensing. J Gastroenterol Hepatol. 2014 Dec; 29 (Suppl 4): 93-8. doi: 10.1111/jgh.12731.

  25. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011 May; 31(5): 986-1000. doi: 10.1161/ATVBAHA.110.207449.

  26. Marzocco S, Di Paola R, Serraino I, Sorrentinoc R, Melic R, Mattaceraso G et al. Effect of methylguanidine in carrageenan-induced acute inflammation in the rats. Eur J Pharmacol. 2004 Jan; 484(2-3): 341-50. doi: 10.1016/j. ejphar.2003.11.011.

  27. Durão J, Vale N, Gomes S, Gomes P, Barrias CC, Gales L. Nitric oxide release from antimicrobial peptide hydrogels for wound healing. Biomolecules. 2018 Dec; 9(1): 4. doi: 10.3390/biom9010004.

  28. Singh A, Chibber P, Kolimi P, Malik TA, Kapoor N, Kumar A et al. Rohitukine inhibits NF-κB activation induced by LPS and other inflammatory agents. Int Immunopharmacol. 2019 Apr; 69: 34-49. doi: 10.1016/j. intimp.2019.01.015.

  29. Nixon M, Upreti R, Andrew R. 5α-Reduced glucocorticoids: a story of natural selection. J Endocrinol. 2012 Feb; 212(2): 111-27. doi: 10.1530/JOE-11-0318.

  30. Biddie SC, Conway-Campbell BL, Lightman SL. Dynamic regulation of glucocorticoid signalling in health and disease. Rheumatology (Oxford). 2012 Mar; 51(3): 403-12. doi: 10.1093/rheumatology/ker215.

  31. Yao X, Chen N, Ma CH, Tao J, Bao JA, Zong-Qi C et al. Ginkgo biloba extracts attenuate lipopolysaccharideinduced inflammatory responses in acute lung injury by inhibiting the COX-2 and NF-κB pathways. Chin J Nat Med. 2015 Jan; 13(1): 52-8. doi: 10.1016/S1875- 5364(15)60006-1.

  32. Myers MJ, Scott ML, Deaver CM, Farrell DE, Yancy HF. Biomarkers of inflammation in cattle determining the effectiveness of anti-inflammatory drugs. J Vet Pharmacol Ther. 2010 Feb; 33(1): 1-8. doi: 10.1111/j.1365-2885.2009.01096.x.

  33. Fattori V, Hohmann MS, Rossaneis AC, Pinho-Ribeiro FA, Verri WA. Capsaicin: current understanding of its mechanisms and therapy of pain and other pre-clinical and clinical uses. Molecules. 2016 Jun; 21(7): 844. doi: 10.3390/molecules21070844.

  34. Tang J, Luo K, Li Y, Chen Q, Tang D, Wang D et al. Capsaicin attenuates LPS-induced inflammatory cytokine production by upregulation of LXRα. Int Immunopharmacol. 2015 Sep; 28(1): 264-9. doi: 10.1016/j.intimp.2015.06.007.

  35. Kim CS, Kawada T, Kim BS, Han IS, Choe SY, Kurata T et al. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal. 2003 Mar; 15(3): 299-306. doi: 10.1016/s0898-6568(02)00086-4.

  36. Steeland S, Libert C, Vandenbroucke RE. A new venue of TNF targeting. Int J Mol Sci. 2018 May; 19(5): 1442. doi: 10.3390/ijms19051442.

  37. Agard M, Asakrah S, Morici LA. PGE2 suppression of innate immunity during mucosal bacterial infection. Front Cell Infect Microbiol. 2013 Aug; 3: 45. doi: 10.3389/fcimb.2013.00045.

  38. Kumar A, Negi G, Sharma SS. Suppression of NF-κB and NF-κB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IκB phosphorylation inhibitor) in experimental diabetic neuropathy. Biochimie. 2012 May; 94(5): 1158-65. doi: 10.1016/j.biochi.2012.01.023.

  39. Ninomiya Y, Tanuma SI, Tsukimoto M. Differences in the effects of four TRPV1 channel antagonists on lipopolysaccharide-induced cytokine production and COX-2 expression in murine macrophages. Biochem Biophys Res Commun. 2017 Mar; 484(3): 668-74. doi: 10.1016/j.bbrc.2017.01.173.

  40. Menéndez L, Juárez L, García E, García-Suárez O, Hidalgo A, Baamonde A. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice. Neurosci Lett. 2006 Jan; 393(1): 70-3. doi: 10.1016/j.neulet.2005.09.046.




2020     |     www.medigraphic.com